TYK MEDICINES-B (02410.HK): Chairman Wu Yusheng Increases Shareholding with Planned Purchases of up to HKD 2 Million, Shares to Be Locked Up for Six Months

NewTimeSpace News: On 8 September 2026, TYK Medicines, Inc. (stock code: 02410) issued a voluntary announcement stating that Dr. Wu Yusheng, chairman, executive director and president of the company, had recently purchased shares of the company on the open market and may continue to purchase shares depending on market conditions, with the total amount of planned increases currently expected not to exceed HKD 2 million.

According to the announcement, Dr. Wu has undertaken to the company that shares acquired through the increases within the coming month will be voluntarily locked up for six months from the respective purchase dates, during which they will not be sold or otherwise transferred. The purchases are funded by his own funds. Dr. Wu said the shareholding increase demonstrates his firm belief in and full confidence in the group's future development prospects.

The company stated that, based on information available to it and to the best of the board's knowledge, immediately after Dr. Wu's increase and as of the date of this announcement, the issued shares of the company continue to maintain sufficient public float under the Listing Rules, and the increase has been conducted in compliance with the Model Code for Securities Transactions by Directors of Listed Issuers set out in Appendix C3 to the Listing Rules.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.